IMS Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,185
Closed -$255K 134
2022
Q2
$255K Buy
+3,185
New +$249K 0.16% 121
2021
Q1
Sell
-2,585
Closed -$221K 130
2020
Q4
$221K Buy
+2,585
New +$214K 0.14% 124
2018
Q4
Sell
-2,085
Closed -$140K 166
2018
Q3
$140K Buy
2,085
+1,800
+632% +$120K 0.09% 129
2018
Q2
$18K Buy
+285
New +$18.6K 0.01% 178
2017
Q1
Sell
-1,600
Closed -$105K 131
2016
Q4
$105K Buy
+1,600
New +$110K 0.11% 132
2015
Q2
Sell
-5,400
Closed -$374K 137
2015
Q1
$374K Buy
+5,400
New +$373K 0.42% 82
2014
Q4
Sell
-9,100
Closed -$594K 157
2014
Q3
$594K Buy
+9,100
New +$600K 0.69% 59

Other funds holding CL

IMS Capital Management's CL Position: Q3 2022 in Review

IMS Capital Management sold out of Colgate-Palmolive (CL) in Q3 2022, closing a stake of 3,185 shares — an estimated $255K sold.

IMS Capital Management first reported a position in CL in Q3 2014 and held it in 7 quarters. The position peaked at $594K in Q3 2014. 1,614 funds tracked by Wall St. Rank hold CL as of Q3 2022.

  • IMS Capital Management reported no remaining Colgate-Palmolive position as of Q3 2022 after selling out during the quarter.
  • IMS Capital Management sold 3,185 Colgate-Palmolive shares in Q3 2022, an estimated $255K.
  • IMS Capital Management first reported a position in Colgate-Palmolive in Q3 2014 and held it in 7 quarters.
  • IMS Capital Management's Colgate-Palmolive position peaked at $594K in Q3 2014.
  • 1,614 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2022.

Based on IMS Capital Management's 13F filing for Q3 2022, filed 17 Nov 2022.